Mary Carrington | |
|---|---|
 | |
| Alma mater | University of Kansas (BS) Iowa State University (MS, PhD) |
| Scientific career | |
| Fields | Immunogenetics |
| Institutions | Duke University Frederick National Laboratory for Cancer Research |
Mary N. Carrington is an American immunologist researching the role of host genetics in cancer, autoimmunity and infectious disease pathogenesis. She is director of the basic science program at the Frederick National Laboratory for Cancer Research.
Carrington graduated from University of Kansas with a B.S. in education, later obtaining her M.S. and Ph.D. in immunobiology from Iowa State University. She performed her postdoctoral studies in the departments of Immunology and Microbiology at Duke University and the University of North Carolina. [1]
Carrington joined the immunology department at Duke University as a faculty member. She moved to the National Cancer Institute at Frederick in 1989. Carrington is the director of the Basic Science Program at the Frederick National Laboratory for Cancer Research, where she is responsible for the guidance and oversight of a large, diverse group of scientists performing investigator-initiated, hypothesis-driven basic research in cancer and AIDS. She is also a senior principal scientist at the National Cancer Institute and heads the Human Leukocyite Antigens Immunogenetics Laboratory in the Cancer and Inflammation Program. Her primary research interests focus on the role of host genetics in cancer, autoimmunity and infectious disease pathogenesis. [1] Her group studies the influence of immunogenetic variation on risk of human disease, outcome to therapeutic treatment, and vaccination. These studies include elucidation of the functional basis for the genetic associations identified. [2] In 2022, she was elected to the American Academy of Arts and Sciences. [3]
The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) is one of the institutes and centers that make up the National Institutes of Health, an agency of the United States Department of Health and Human Services (HHS).
The Vaccine Research Center (VRC), is an intramural division of the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), US Department of Health and Human Services (HHS). The mission of the VRC is to discover and develop both vaccines and antibody-based products that target infectious diseases.
Francesco Dieli is an Italian immunologist. He was born in Prizzi, Italy. After high school education, in 1983 he got his degree with honors in Medicine at the University of Palermo where he specialized in Pathology. He got his PhD in Immunology in 1999. He is full professor of Immunology and Director of the Division of Immunology and Immunogenetics at the University of Palermo, Italy.
Andrew D. Luster is the Persis, Cyrus and Marlow B. Harrison Professor of Medicine at Harvard Medical School, and the Chief of the Division of Rheumatology, Allergy and Immunology at Massachusetts General Hospital. He is Director of its Research Center for Immunology and Inflammatory Diseases, and a member of the Dana-Farber/Harvard Cancer Center's Cancer Immunology program.
Keiko Ozato is a Japanese American geneticist whose research has focused on gene regulation in the developing immune system; She is best known for her contributions to immunogenetics and epigenetics in isolating the IRF8 transcription factor that aids humans in fighting off disease and for identifying the BRD4 protein that regulates cellular and viral genes that can invoke epigenetic memory. She is Senior Investigator at the Section on Molecular Genetics of Immunity at the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) at the National Institutes of Health in Bethesda, Maryland and a professor at the University of Maryland, College Park.
Georgia Mae Dunston is an American geneticist who is professor of human immunogenetics at Howard University and founding director of the National Human Genome Center at Howard University.
Bonnie Jean Mathieson was an American biomedical scientist and pioneer in HIV vaccine research. Mathieson worked at the National Institutes of Health (NIH) for 43 years. She played a fundamental role in NIH HIV/AIDS research, vaccine programs, and scientific policy.
Franziska B. Grieder is a Swiss-American veterinary scientist. She is the director of the Office of Research Infrastructure Programs at the National Institutes of Health. Grieder was a faculty member and researcher at the Uniformed Services University of the Health Sciences.
Sonja Marie Best is an Australian-American virologist. She is chief of the innate immunity and pathogenesis section at the Rocky Mountain Laboratories. Best researches interactions between pathogenic viruses and the host immune response using flavivirus as a model.
Emmie de Wit is a Dutch-American virologist. She is chief of the molecular pathogenesis unit at the Rocky Mountain Laboratories. Her research combines pathogenesis studies with detailed molecular analyses to identify molecular determinants of severe respiratory tract disease within the virus and the host.
Kim Yarbrough Green is an American virologist. She is chief of the caliciviruses section in the laboratory of infectious diseases at the National Institute of Allergy and Infectious Diseases. She researches noroviruses in human disease, disease prevention, and control strategies.
Niki M. Moutsopoulos is a Greek periodontist and immunologist. She is a senior investigator in the oral immunity and infection section at the National Institute of Dental and Craniofacial Research. Moutsopoulos specializes in oral immunology and periodontitis. Her research program focuses on host-microbial interactions that can drive chronic inflammatory responses and tissue destruction in the oral cavity.
Karen M. Frank is an American clinical pathologist and microbiologist researching the pathogenesis of Staphylococcus aureus pneumonia and resistant gram-negative bacteria. She is a senior clinician, principal investigator, and chief of laboratory medicine at the National Institutes of Health Clinical Center.
Jacqueline Marion Katz is an Australian-American microbiologist serving as the deputy director of the influenza division at the National Center for Immunization and Respiratory Diseases.
Barbara K. Felber is an American biologist specialized in human retrovirus pathogenesis and gene regulation. She is a senior investigator in the vaccine branch at the National Cancer Institute.
Silvana Romina Goldszmid is an Argentine-American biologist researching tumor immunology. She is an NIH Stadtman Investigator at the National Cancer Institute.
Mary Elizabeth Daucher is an American biologist serving as the acting chief of the vaccine production program laboratory at Vaccine Research Center of the National Institute of Allergy and Infectious Diseases.
Joy Ann Williams was an American immunologist at the National Cancer Institute where she researched the biology of thymic development.
Beverly Anne Mock is an American geneticist who is a deputy director of the National Cancer Institute's Center for Cancer Research.
Lisa J. Mirabello is an American medical geneticist who researches genetic susceptibility to pediatric cancer and the genomics of HPV carcinogenicity. She is a senior investigator in the clinical genetics branch at the National Cancer Institute.
This article incorporates text from this source, which is in the public domain . This article incorporates text from this source, which is in the public domain . This article incorporates public domain material from websites or documents of the National Institutes of Health.| International | |
|---|---|
| National | |
| Academics | |
| Other | |
